Sei sulla pagina 1di 4

TREATMENT FOR TB

Treatment Guidelines for Tuberculosis (RIPE)


Preventive Therapy
Prophylaxis in Patients with negative TB skin test

Isoniazid for 3 months

Preventive Therapy in Patients with Positive Skin Test

Isoniazid for 9 months Rifampin for 4 months Give pyridoxine (Vit B6)

Subclinical Infection

Isoniazid for 1 year

Active Tuberculosis (RIP --> RI; RIPE or RESPI for resistant forms)
Conventional Therapy for susceptible organisms

1st 2 months: Rifampin + Isoniazid + Pyrazinamide Next 4 months: Rifampin + Isoniazid

Possibly Resistant Organisms or Patients with HIV (RIPE, RIPS or RESPI)

Rifampin + Isoniazid + Pyrazinamide Ethambutol or Streptomycin

Tuberculosis resistant to Isoniazid

Rifampin + Ethambutol for 12 months Pyrazinamide

Multi-Drug Resistant Organisms

Combination of at least 3 drugs to which organisms are susceptible

Pyrazinamide is used for short term (~2 month) therapy as a sterilizing agent against residual intracellular organisms that may cause a relapse of infection by tubercle bacilli. Once the intracellular form has been killed after ~ 2 months of therapy, it no longer needs to be included in the drug combination. It produces hepatoxicity, as does isoniazid. RESPI - as in TB is most commonly a RESPIratory infection

CDC Treatment Algorithms

NOTE: Ethambutol is added to prevent development of resistance to the other medications; it can be dropped from the RIPE drug regimen if no resistance is observed. Legend: INH - Isoniazid; RIF - Rifampin; EMB - Ethambutol; PZA - Pyrazinamide

Potrebbero piacerti anche